Failed methotrexate termination of pregnancy: A case report

Journal of Perinatology

Volumn 26, Issue 10, 2006, Pages 645-647

  Goffman, D ^a   Cole, D S ^a   Bobby, P ^a   Garry, D J ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DICLOFENAC; METHOTREXATE; MISOPROSTOL;

ADULT; ARTICLE; BIOMETRY; CASE REPORT; DOPPLER ECHOGRAPHY; FACE DYSMORPHIA; FEMALE; FETUS; FETUS ECHOGRAPHY; FETUS MALFORMATION; FOLLOW UP; GENITAL MALFORMATION; GESTATIONAL AGE; HISPANIC; HUMAN; INTRAUTERINE GROWTH RETARDATION; MALE; MENTAL STRESS; MICROPENIS; PATIENT COUNSELING; PREGNANCY TERMINATION; PRENATAL CARE; PRENATAL DIAGNOSIS; RIB MALFORMATION; RISK REDUCTION; SCOLIOSIS; THORAX RADIOGRAPHY; TREATMENT FAILURE; UMBILICAL ARTERY;

ABNORMALITIES, MULTIPLE; ABORTIFACIENT AGENTS, NONSTEROIDAL; ABORTION, INDUCED; ADULT; FEMALE; HUMANS; INFANT, NEWBORN; MALE; METHOTREXATE; MISOPROSTOL; PREGNANCY; PREGNANCY OUTCOME; PREGNANCY TRIMESTER, FIRST;

EID: 33749370860     PISSN: 07438346     EISSN: 14765543     Source Type: Journal    
DOI: 10.1038/sj.jp.7211563     Document Type: Article

References (13)

1. Nguyen CN, Duhl AJ, Escallon CS, Blakemore KJ. Multiple anomalies in a fetus exposed to low-dose methotrexate in the first trimester. Obstet Gynecol 2002; 99: 599-602.
2. Warkany J, Beaudry PH, Hornstein S. Attempted abortion with aminopterin (4-aminopteroylglutamic acid). Am J Dis Child 1959; 97: 274-281.
3. Milunsky A, Graef JW, Gaynor MF. Methotrexate-induced congenital malformations. With a review of the literature. J Pediatr 1968; 72: 790-795.
4. Buckley LM, Bullaboy CA, Leichtman L, Marquez M. Multiple congenital anomalies associated with weekly low-dose methotrexate treatment of the mother. Arthritis Rheum 1997; 40: 971-973.
5. Addar MH. Methotrexate embryopathy in a surviving intrauterine fetus after presumed diagnosis of ectopic pregnancy: Case report. J Obstet Gynaecol Can 2004; 26: 1001-1003.
6. Gonzalez CH, Marques-Dias MJ, Chong AK, Sugayama SM, De Paz JA, Huson SM et al. Congenital abnormalities in Brazilian children associated with misoprostol misuse in first trimester of pregnancy. Lancet 1998; 351: 1624-1628.
7. Chapa JB, Hibbard JU, Weber FM, Abramowicz JS, Verp MS. Prenatal diagnosis of methotrexate embryopathy. Obstet Gynecol 2003; 101: 1104-1107.
8. Lewden B, Vial T, Elefant F, Nelva A, Carlier P, Descotes J, French Network of Regional Pharmacovigilance Centers. Low dose methotrexate in the first trimester of pregnancy: Results of a French collaborative study. J Rheumatol 2004; 31(12): 2360-2365.
9. Schaff EA, Penmetsa U, Eisinger SH, Franks P. Methotrexate. A single agent for early abortion. J Reprod Med 1997; 42: 56-60.
10. Goldberg AB, Greenberg MB, Darney PD. Misoprostol and pregnancy. N Engl J Med 2001; 344(1): 38-47.
11. Yedlinsky NT, Morgan FC, Whitecar PW. Anomalies associated with failed methotrexate and misoprostol termination. Obstet Gynecol 2005; 105: 1203-1205.
12. Feldkamp M, Carey JC. Clinical teratology counseling and consultation case report: Low dose methotrexate exposure in the early weeks of pregnancy. Teratology 1993; 47: 533-539.
13. http://www.fda.gov/cder/drug/infopage/mifepristone/default.htm.